You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 130 No. 3, March 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  The Cutting Edge
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Debilitating Verruca Vulgaris in a Patient Infected With the Human Immunodeficiency Virus

Dramatic Improvement With Hyperthermia Therapy

Sewon Kang, MD; Thomas B. Fitzpatrick, MD, PhD

Arch Dermatol. 1994;130(3):294-296.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

REPORT OF A CASE

A 42-year-old white man with human immunodeficiency virus (HIV) infection of 4 years' duration was admitted to Massachusetts General Hospital, Boston, for debilitating exacerbation of psoriasis. The skin condition, present for 3 years, had been reasonably controlled with UV-B phototherapy. For several weeks before admission, the patient had difficulty getting to the light therapy unit on a regular basis because of ambulatory problems. Progressively enlarging ''warts'' on his toes were becoming too painful for the patient to walk very far. Oxycodone with acetaminophen, morphine sulfate, and amitriptyline prescribed for his alcoholic neuropathy, manifested as leg pain, were being used for control of his toe pain. Except for HIV-associated hematologic changes, he had no other significant medical problems. In addition to the pain control medications, he was receiving zidovudine and ranitidine. He had no prior therapy for lesions on his toes.

Findings from his physical examination revealed . . . [Full Text PDF of this Article]


Author Affiliations

Harvard Medical School, Boston, Mass



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.